198 related articles for article (PubMed ID: 18209879)
21. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.
Wake DJ; Walker BR
Endocrine; 2006 Feb; 29(1):101-8. PubMed ID: 16622297
[TBL] [Abstract][Full Text] [Related]
22. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue.
Sutinen J; Kannisto K; Korsheninnikova E; Nyman T; Ehrenborg E; Andrew R; Wake DJ; Hamsten A; Walker BR; Yki-Järvinen H
Diabetologia; 2004 Oct; 47(10):1668-71. PubMed ID: 15455200
[TBL] [Abstract][Full Text] [Related]
23. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome.
Mariniello B; Ronconi V; Rilli S; Bernante P; Boscaro M; Mantero F; Giacchetti G
Eur J Endocrinol; 2006 Sep; 155(3):435-41. PubMed ID: 16914598
[TBL] [Abstract][Full Text] [Related]
24. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
Tomlinson JW; Moore J; Cooper MS; Bujalska I; Shahmanesh M; Burt C; Strain A; Hewison M; Stewart PM
Endocrinology; 2001 May; 142(5):1982-9. PubMed ID: 11316764
[TBL] [Abstract][Full Text] [Related]
25. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats.
Barat P; Livingstone DE; Elferink CM; McDonnell CR; Walker BR; Andrew R
Endocrinology; 2007 Oct; 148(10):4836-43. PubMed ID: 17628001
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
Wamil M; Seckl JR
Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
[TBL] [Abstract][Full Text] [Related]
27. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
28. Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling.
Simonyte K; Rask E; Näslund I; Angelhed JE; Lönn L; Olsson T; Mattsson C
Obesity (Silver Spring); 2009 Nov; 17(11):1982-7. PubMed ID: 19360009
[TBL] [Abstract][Full Text] [Related]
29. Systemic overexpression of the 11β‑HSD1 promotes endoplasmic reticulum stress in multiple tissues and the development of metabolic syndrome in mice.
Li C; Xia J; Zhu W; Xin L; An C; Yang S; Li K
Mol Med Rep; 2017 Nov; 16(5):7738-7744. PubMed ID: 28944856
[TBL] [Abstract][Full Text] [Related]
30. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory.
Seckl JR; Walker BR
Trends Endocrinol Metab; 2004 Nov; 15(9):418-24. PubMed ID: 15519888
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease.
Morton NM; Ramage L; Seckl JR
Endocrinology; 2004 Jun; 145(6):2707-12. PubMed ID: 15044372
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoids in adipocytes stimulate visceral obesity.
Wolf G
Nutr Rev; 2002 May; 60(5 Pt 1):148-51. PubMed ID: 12030279
[TBL] [Abstract][Full Text] [Related]
33. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Wake DJ; Walker BR
Mol Cell Endocrinol; 2004 Feb; 215(1-2):45-54. PubMed ID: 15026174
[TBL] [Abstract][Full Text] [Related]
34. Contribution of local regeneration of glucocorticoids to tissue steroid pools.
Khan S; Livingstone DEW; Zielinska A; Doig CL; Cobice DF; Esteves CL; Man JTY; Homer NZM; Seckl JR; MacKay CL; Webster SP; Lavery GG; Chapman KE; Walker BR; Andrew R
J Endocrinol; 2023 Sep; 258(3):. PubMed ID: 37343234
[TBL] [Abstract][Full Text] [Related]
35. Does central obesity reflect "Cushing's disease of the omentum"?
Bujalska IJ; Kumar S; Stewart PM
Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
[TBL] [Abstract][Full Text] [Related]
36. Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men.
Anderson AJ; Andrew R; Homer NZM; Hughes KA; Boyle LD; Nixon M; Karpe F; Stimson RH; Walker BR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1206-e1220. PubMed ID: 33270115
[TBL] [Abstract][Full Text] [Related]
37. Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients.
Torrecilla E; Fernández-Vázquez G; Vicent D; Sánchez-Franco F; Barabash A; Cabrerizo L; Sánchez-Pernaute A; Torres AJ; Rubio MA
Obes Surg; 2012 Mar; 22(3):478-86. PubMed ID: 21964795
[TBL] [Abstract][Full Text] [Related]
38. 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance.
Koska J; de Courten B; Wake DJ; Nair S; Walker BR; Bunt JC; Permana PA; Lindsay RS; Tataranni PA
Obesity (Silver Spring); 2006 Sep; 14(9):1515-22. PubMed ID: 17030962
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
